While much of the focus around DSHEA was on Capitol Hill and the machinations of government, an important behind-the-scenes contribution came from the short lived Natural Products Quality Assurance Alliance. But what was NPQAA and how did it help?
FDA has reiterated its enforcment stance on CBD and hemp products, has updated a Q&A document on the subject and has specified what kind of information it is seeking in the runup to a public meeting on the subject in May, all as part of documents...
FDA has sent three companies marketing CBD products warning letters over disease claims. The warnings are the first issued under FDA’s de facto ‘enforcement discretion’ policy, which will be discussed at a meeting on CBD set for the end of May.
A paper published by a group of medicinal biochemistry researchers provides a comprehensive look at the challenges of selecting well characterized materials for testing, including a list of recommendations for best practices.
The world of hemp and CBD products sits at a critical moment in its history, much as the dietary supplement industry did a quarter century ago, according to one of the experts who was there at the birth of the industry.
Bodybuilding.com’s John Venardos shares some of his ideas to improve the regulation of the dietary supplements industry, from better transparency to greater FDA staff accountability, and how to level the playing field.
Alkemist also announces reduction in turnaround time for routine tests
Third party botanical ID test results from Alkemist Labs are now available at ingredientsonline.com for select botanicals, as the online ingredient platform continues to push the transparency envelope.